If a picture paints a thousand words, a hashtag #PaintstheWholePicture! #eliminateRNB2025 embodies our mission to eliminate residual neuromuscular block in patients around the world by 2025. This is an important goal, as residual neuromuscular block can cause increased oxygen desaturation, postoperative pneumonia, airway obstruction, and reintubation, as well as increase healthcare costs associated with these…
If a picture paints a thousand words, a hashtag #PaintstheWholePicture! #eliminateRNB2025 embodies our mission to eliminate residual neuromuscular block in patients around the world by 2025. This is an important goal, as residual neuromuscular block can cause increased oxygen desaturation, postoperative pneumonia, airway obstruction, and reintubation, as well as increase healthcare costs associated with these…
The latest guidelines from the American Society of Anesthesiologists (ASA) and the European Society of Anaesthesiology and Intensive Care Medicine (ESAIC) provide important recommendations for quantitative monitoring and antagonism of neuromuscular blockade. These guidelines are based on recent evidence-based research, and they place particular emphasis on using quantitative monitoring. Let’s look at the four main…
Standard anaesthesia practice involves the use of neuromuscular blocking agents (NMBAs) to facilitate intubation as well as improve surgical conditions by enabling muscle relaxation during the surgical procedure. Whenever NMBAs are given during anaesthesia, it is mandatory to monitor the degree of neuromuscular blockade (NMB).1 This can be done using subjective or objective methods of…
Drug-induced neuromuscular blockade is often used in anesthesia to enable endotracheal intubation, optimize surgical conditions, and assist with mechanical ventilation in patients who have reduced lung performance. Neuromuscular blocking drugs, or agents (NMBAs), act by inhibiting signal transduction at the motor end plate, thus resulting in reversible paralysis of skeletal muscles. The use of NMBAs…
Sugammadex vs Neostigmine: How the Effective Use of Sugammadex Reduces Costs Postoperative residual curarization (PORC) frequently occurs following anesthesia and may be associated with the development of pulmonary complications, such as labored breathing, hypoxemia, and aspiration pneumonia. It may also result in a postoperative reduction in muscle strength that can cause an increase in recovery…
Increased PACU Length of Stay – A Costly Matter Postoperative residual curarization (PORC), also known as residual neuromuscular blockade, refers to the residual muscle paralysis that occurs after emergence from general anesthesia. PORC stems from the use of neuromuscular blocking agents (NMBAs). It is defined as a Train-of-Four (TOF) ratio of <0.9 and may occur…
The Cost of Postoperative Respiratory Adverse Events Respiratory impairment following general anaesthesia can pose a significant problem. Adverse and critical respiratory events (AREs and CREs) have been responsible for increased morbidity and mortality. The main cause of AREs after surgery is related to the use of neuromuscular blockers (NMBAs) during general anaesthesia. The action of…
Why Quantitative NMT Monitoring is Critical in Surgical Patients and How Best to Do It Some sort of assessment of neuromuscular transmission (NMT) is necessary in surgical patients by clinicians and anesthetists to get a feel for the depth of anesthesia. This assessment can be done using simple yet subjective clinical parameters or through more…
The Stimpod NMS450X+, equipped with two different modalities (AMG and EMG), empowers anaesthesiologists to achieve safer intraoperative control of patients’ neuromuscular blockade. The full case NMT Monitoring enables safe extubation and eliminate residual paralysis in any hospital setting, provider preference and surgery type. This advanced technology empowers clinicians to have a safer and more precise control over the neuromuscular blockade during surgery, aligning with the latest guideline-concordant recommendations for the monitoring of patients for residual paralysis following the administration of a neuromuscular reversal agent. The ASA and ESAIC strongly recommend the use of a quantitative neuromuscular blocking agent monitor in conjunction with neuromuscular blocking agents.
While reversal drugs like Sugammadex are commonly used for NMBA reversal, they are not a foolproof solution and residual paralysis remains a significant concern based on clinical evidence. By incorporating the Stimpod NMS450X+ into their practice, anaesthesiologists can proactively monitor the depth of neuromuscular blockade, significantly reducing the incidence of residual paralysis in patients. This contributes to improved patient outcomes and a safer post-operative recovery.
The Stimpod NMS450X+ offers a cost-effective solution in the OR, PACU and ICU. With its two modalities, AMG and EMG, the device provides flexibility in monitoring options. The only neuromuscular monitoring system available with both AMG and EMG enabling cost control at the point-of-care based on need and specific setting, allowing affordable standardisation across the entire hospital. Cost of Care model, enabling monitoring of all drug usage to ensure optimal use, thus saving on both paralytic and recovery agents. This cost-saving feature ensures efficient resource management without compromising patient safety.
AMG offers the most cost-effective option to implement with a reusable sensor and versatile patient setup options enabling neuromuscular transmission monitoring of the hand, toe or face.
EMG is ideally suited for neuromuscular monitoring of surgeries where tucked hands and arms are required, with optimised performance through a patented, skin-like electrode.
Residual neuromuscular blockade after anaesthesia has been linked to severe complications and adverse outcomes, including increased oxygen desaturation, postoperative pneumonia, airway obstruction, and reintubation. By utilizing the Stimpod NMS450X+ and effectively preventing residual NMB, clinicians can contribute to reduced LOS in hospitals and improve patient recovery rates.
Anaesthesiologists worldwide who have adopted the Stimpod NMS450X+ demonstrate their commitment to following the latest guidelines and best practices in anaesthesia. By incorporating a quantitative NMBA monitor into their practice, clinicians align themselves with the recommendations set forth by the ASA and ESAIC, promoting a higher standard of care and patient safety. By utilizing the Stimpod NMS450X+, anaesthesiologists are a testament to its effectiveness to improve patients outcomes and can contribute to the reduction of adverse events and enhance the recovery process for their patients.
